维普中文期刊产品整合服务
18篇 您的检索式:作者名="Culp SH"
    题名 作者 年代 出处 被引量
1Safety of presurgi- cal targeted therapy in the setting of metastatic renal cell carcino- ma显示文摘Chapin BF Delaeroix Jr SE Culp SH 2011European urology2011,60,5:1
2Refining patient selection for neoadjuvant chemotherapy before radical cysteetomy显示文摘CULP SH DICKSTEIN RJ GROSSMAN HB 2014J Urol2014,191,1:1
3Limitations of preoperative biopsy in patients with metastatic renal cell carcinoma: comparison to surgical pathology in 405 cases显示文摘ABEL EJ CARRASCO A CULP SH 2012BJU Int2012,110,11:1
4Primary tumor response to targeted agents in patients with metastatic renal cell carcinoma 显示文摘Abel EJ Culp SH Tannir NM 2011European urology2011,59,1:1
5Identifying the risk of disease progression after surgery for localized renal cell carcinoma显示文摘Abel EJ Culp SH Meissner M 2010BJU Int2010,106,:1
6Outcome of pa- tients with metastatic renal cell carcinoma treated with targeted therapy without cytoreductivc nephrectomy显示文摘RICHEY SL CULP SH JONASCH E 2011Ann Oncol2011,22,5:1
7Refining patient selection for neoadjuvant chemotherapy before radical cystectomy 显示文摘Culp SH Dickstein RJ Grossman HB 2014J Urol2014,191,1:1
8Early primary tumor size reduction is an independent predictor of improved o- verall survival in metastatic renal cell carcinoma patients treated with sunitinib显示文摘ABEL EJ CULP SH TANNIR NM 2011Eur Urol2011,60,6:1
9Identifying the risk of disease progression after surgery for localized renal cell carcinoma 显示文摘Abel EJ Culp SH Meissner M 2010BJU Int2010,106,9:1
10Primary tumor response to targeted agents in patients with metastatic renal cell carcinoma 显示文摘Abel EJ Culp SH Tannir NM 2011Ear Urol2011,59,1:1
11Primary tumor response to targeted agents in patients with metastatic renal cell carcinoma 显示文摘Abel EJ Culp SH Tannir NM 2011Eur Urol2011,59,1:1
12Population-based analysis of factors associated with survival in patients undergoing cytoreductive nephrectomy in the targeted therapy era显示文摘CULP SH KARAM JA WOOD CG 2014Urol Oncol2014,32,5:1
13Mightmen diagnosed with metastatic prostate cancer benefit from de nitive treatment of the primary tumor? A SEER-based study 显示文摘Culp SH Schellhammer PF Williams MB 2014Eur Urol2014,65,6:1
14Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study 显示文摘Culp SH Sehellhammer PF Williams MB 2014Eur Urol2014,65,:1
15Might men diagnosedwith metastatic prostate cancer benefit from definitive treatment ofthe primary tumor? A SEER-based study显示文摘Culp SH Schellhammer PF Williams MB 2014Eur Urol2014,65,:1
16Percutaneous biopsy of primary tumor in metastatic renal cell carcinoma to predict high risk pathological features:comparison with nephrectomy assessment显示文摘Abel EJ Culp SH Matin SF 0,,05:1
17Safety of presurgical targeted therapy in the setting of metastatic renal cell carcinoma显示文摘Chapin BF Delacroix SE Jr Culp SH 0,,05:1
18Might men diagnosed with metastatic prostate cancer benefit from de- finitive treatment of the primary tumor? A SEER-based study 显示文摘CULP SH SCHELLHAMMER PF WILLIAMS MB 2014Eur Urol2014,65,6:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费